ATORVASTATIN

 Trade Names: atrolip , Atorva, Atorex Lipitor, Torvast, Totalip, Ator, Tahor, Statinor, Torva, Atoris, Sortis, Torvacard, Tulip. 


Classification: Atorvastatin is a pyrrole and heptanoic corrosive derivative,hydroxymethylglutaryl-coa reductase inhibitor (statin), and anticholesteremic specialist 


Indications: Hyperlipidemia like essential hypercholesterolemia and blended dyslipidemia (raised LDL-cholesterol and fatty oil), hypertriglyceridemia, Familial Hypercholesterolemia. 


Counteraction of Cardiovascular Disease. 


Mechanism of Action: Atorvastatin seriously represses hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, the chemical which catalyzes the change of HMG-CoA to mevalonate, a critical advance in cholesterol union. This specialist expands the quantity of LDL receptors on hepatic cell surfaces, improving the take-up and catabolism of LDL and decreasing LDL creation and the quantity of LDL particles, and brings down plasma cholesterol and lipoprotein levels 


Side Effects: The most generally revealed unfriendly responses include: nasopharyngitis (irritation of the nasal entries, torment in the throat), nose drain, joint agony, muscle torment, back torment, loose bowels, and urinary parcel contamination and consumption of CoQ10.

Comments

Popular posts from this blog

ALLOPURINOL

Non-alcoholic fatty liver disease- causes, symptoms, diagnosis, treatment, pathology

Sudden Cardiac arrest